Anlon Healthcare Limited (NSE:AHCL)

India flag India · Delayed Price · Currency is INR
128.86
+12.22 (10.48%)
At close: Mar 9, 2026
Market Cap 6.85B
Revenue (ttm) 1.70B
Net Income (ttm) 346.64M
Shares Out 53.15M
EPS (ttm) 7.84
PE Ratio 16.43
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,652,199
Average Volume 147,104
Open 116.00
Previous Close 116.64
Day's Range 113.40 - 133.00
52-Week Range 90.78 - 172.75
Beta n/a
RSI 46.32
Earnings Date Feb 9, 2026

About Anlon Healthcare

Anlon Healthcare Limited manufactures and sells advance pharmaceutical intermediates in India and internationally. The company offers active pharmaceutical ingredients (API); nutraceutical API products; personal care ingredients; and veterinary API products. Its products are used in anti-inflammatory (NSAID), analgesic, antipyretic, antihistamine, antidepressant, antipsychotic, anticoagulant, antihypertensive, nutrition, anti-arrhythmic, anti-hyper parathyroid, antiplatelet, ant diabetic, gastroesophageal reflux disease (GERD), and anti-rheumat... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 2013
Employees 117
Stock Exchange National Stock Exchange of India
Ticker Symbol AHCL
Full Company Profile

Financial Performance

In fiscal year 2025, Anlon Healthcare's revenue was 1.20 billion, an increase of 80.64% compared to the previous year's 666.16 million. Earnings were 205.18 million, an increase of 112.46%.

Financial Statements

News

There is no news available yet.